Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AQS | TSXV | CAD | Delayed | |
AQS | CBOE Canada | CAD | Real-time |
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada. The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma. It also develops REV-0100 for the treatment of stargardt disease that is in pre-clinical trial. The company has a strategic collaboration with reVision for the development of a therapy for stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
Douglas Glen Janzen | 54 | 2013 | Chairman, CEO & President |
Christopher Clark | 51 | 2014 | Director |
Ken Patterson | - | 2018 | Member of Strategic Advisory Board |
Anne Michelle Stevens | 42 | 2014 | Director |
Iqbal K. Ahmed | - | 2018 | Chairman of Strategic Advisory Board |
Vikram Lekhi | - | 2018 | Member of Strategic Advisory Board |
Rosa Braga-Mele | - | 2018 | Member of Strategic Advisory Board |
Marc Lustig | 49 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review